Neil STAHL

Person

Carmel, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Human antibodies to ebola virus glycoprotein
- Patent number 12,152,067
- Issue date Nov 26, 2024
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF traps and mini-traps and methods for treating ocular disorders...
- Patent number 12,103,960
- Issue date Oct 1, 2024
- REGENERON PHARMACEUTICALS, INC.
- William Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...
- Patent number 11,732,030
- Issue date Aug 22, 2023
- REGENERON PHARMACEUTICALS, INC.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to Ebola virus glycoprotein
- Patent number 11,530,255
- Issue date Dec 20, 2022
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating allergy and enhancing allergen-specific immuno...
- Patent number 11,485,788
- Issue date Nov 1, 2022
- REGENERON PHARMACEUTICALS, INC.
- Neil Stahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding f...
- Patent number 10,975,139
- Issue date Apr 13, 2021
- REGENERON PHARMACEUTICALS, INC.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...
- Patent number 10,954,289
- Issue date Mar 23, 2021
- Regeneren Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to Ebola virus glycoprotein
- Patent number 10,829,544
- Issue date Nov 10, 2020
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...
- Patent number 10,787,501
- Issue date Sep 29, 2020
- REGENERON PHARMACEUTICALS, INC.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating allergy and enhancing allergen-specific immuno...
- Patent number 10,676,530
- Issue date Jun 9, 2020
- REGENERON PHARMACEUTICALS, INC.
- Neil Stahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating allergy and enhancing allergen-specific immuno...
- Patent number 10,669,341
- Issue date Jun 2, 2020
- Neil Stahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolating cells expressing secreted proteins
- Patent number 10,598,669
- Issue date Mar 24, 2020
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- G01 - MEASURING TESTING
Information Patent Grant
Human antibodies to Ebola virus glycoprotein
- Patent number 10,501,526
- Issue date Dec 10, 2019
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to Middle East Respiratory Syndrome—coronavirus sp...
- Patent number 10,406,222
- Issue date Sep 10, 2019
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating allergy and enhancing allergen-specific immuno...
- Patent number 10,392,439
- Issue date Aug 27, 2019
- Regeneron Pharmaceuticals, Inc.
- Neil Stahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolating cells expressing secreted proteins
- Patent number 10,261,093
- Issue date Apr 16, 2019
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- G01 - MEASURING TESTING
Information Patent Grant
Human antibodies to Ebola virus glycoprotein
- Patent number 10,081,670
- Issue date Sep 25, 2018
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to NAv1.7
- Patent number 10,072,076
- Issue date Sep 11, 2018
- REGENERON PHARMACEUTICALS, INC.
- Lynn MacDonald
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human antibodies to ebola virus glycoprotein
- Patent number 9,771,414
- Issue date Sep 26, 2017
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to middle east respiratory syndrome—coronavirus sp...
- Patent number 9,718,872
- Issue date Aug 1, 2017
- REGENERON PHARMACEUTICALS, INC.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PCSK9 antibodies with pH-dependent binding characteristics
- Patent number 9,540,449
- Issue date Jan 10, 2017
- REGENERON PHARMACEUTICALS, INC.
- George D. Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolating cells expressing secreted proteins
- Patent number 9,389,236
- Issue date Jul 12, 2016
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Receptor based antagonists and methods of making and using
- Patent number 7,927,583
- Issue date Apr 19, 2011
- REGENERON PHARMACEUTICALS, INC.
- Neil Stahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating diseases with a VEGF antagonist
- Patent number 7,531,172
- Issue date May 12, 2009
- REGENERON PHARMACEUTICALS, INC.
- Neil Stahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolating cells expressing secreted proteins
- Patent number 7,435,553
- Issue date Oct 14, 2008
- REGENERON PHARMACEUTICALS, INC.
- James P. Fandl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IL-1 receptor based cytokine traps and method of using
- Patent number 7,417,134
- Issue date Aug 26, 2008
- REGENERON PHARMACEUTICALS, INC.
- Neil Stahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of an IL-1 antagonist for treating arthritis
- Patent number 7,361,350
- Issue date Apr 22, 2008
- REGENERON PHARMACEUTICALS, INC.
- Scott Mellis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating anemia by inhibition of vascular endothelial gr...
- Patent number 7,351,411
- Issue date Apr 1, 2008
- REGENERON PHARMACEUTICALS, INC.
- Jocelyn Holash
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic method for treating bone formation diseases
- Patent number 7,285,532
- Issue date Oct 23, 2007
- REGENERON PHARMACEUTICALS, INC.
- Aris N. Economides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Morphogenic protein
- Patent number 7,241,739
- Issue date Jul 10, 2007
- REGENERON PHARMACEUTICALS, INC.
- David M. Valenzuela
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN
- Publication number 20240327501
- Publication date Oct 3, 2024
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND CO...
- Publication number 20240254208
- Publication date Aug 1, 2024
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS...
- Publication number 20240124554
- Publication date Apr 18, 2024
- Regeneron Pharmaceuticals, Inc.
- William OLSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...
- Publication number 20230348569
- Publication date Nov 2, 2023
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNO...
- Publication number 20230159647
- Publication date May 25, 2023
- Regeneron Pharmaceuticals, Inc.
- Neil STAHL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...
- Publication number 20220356230
- Publication date Nov 10, 2022
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS
- Publication number 20220195058
- Publication date Jun 23, 2022
- Regeneron Pharmaceuticals, Inc.
- Michael DUNN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND CO...
- Publication number 20220153819
- Publication date May 19, 2022
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS...
- Publication number 20210347852
- Publication date Nov 11, 2021
- Regeneron Pharmaceuticals, Inc.
- William OLSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN
- Publication number 20210024617
- Publication date Jan 28, 2021
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isolating Cells Expressing Secreted Proteins
- Publication number 20200326349
- Publication date Oct 15, 2020
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING
Information Patent Application
Multivalent Antigen-Binding Proteins
- Publication number 20200299414
- Publication date Sep 24, 2020
- Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNO...
- Publication number 20200299393
- Publication date Sep 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Neil STAHL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN
- Publication number 20200148751
- Publication date May 14, 2020
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isolating Cells Expressing Secreted Proteins
- Publication number 20190376981
- Publication date Dec 12, 2019
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Human Antibodies to Middle East Respiratory Syndrome - Coronavirus...
- Publication number 20190351049
- Publication date Nov 21, 2019
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- G01 - MEASURING TESTING
Information Patent Application
HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN
- Publication number 20190048066
- Publication date Feb 14, 2019
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Allergy and Enhancing Allergen-Specific Immuno...
- Publication number 20180094070
- Publication date Apr 5, 2018
- Regeneron Pharmaceuticals, Inc.
- Neil STAHL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Allergy and Enhancing Allergen-Specific Immuno...
- Publication number 20180094069
- Publication date Apr 5, 2018
- Regeneron Pharmaceuticals, Inc.
- Neil STAHL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN
- Publication number 20170355751
- Publication date Dec 14, 2017
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies to Middle East Respiratory Syndrome - Coronavirus...
- Publication number 20170340728
- Publication date Nov 30, 2017
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIVALENT ANTIGEN-BINDING PROTEINS
- Publication number 20170260293
- Publication date Sep 14, 2017
- Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIVALENT ANTIGEN-BINDING PROTEINS
- Publication number 20170247474
- Publication date Aug 31, 2017
- Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isolating Cells Expressing Secreted Proteins
- Publication number 20170241887
- Publication date Aug 24, 2017
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING
Information Patent Application
Human Antibodies to Ebola Virus Glycoprotein
- Publication number 20160215040
- Publication date Jul 28, 2016
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOLATING CELLS EXPRESSING SECRETED PROTEINS
- Publication number 20160033530
- Publication date Feb 4, 2016
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING
Information Patent Application
HUMAN ANTIBODIES TO NAV1.7
- Publication number 20160024208
- Publication date Jan 28, 2016
- Regeneron Pharmaceuticals, Inc.
- Lynn MacDonald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies to Middle East Respiratory Syndrome - Coronavirus...
- Publication number 20150337029
- Publication date Nov 26, 2015
- Regeneron Pharmaceuticals, Inc.
- Christos Kyratsous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTIVALENT ANTIGEN-BINDING PROTEINS
- Publication number 20150203591
- Publication date Jul 23, 2015
- Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOLATING CELLS EXPRESSING SECRETED PROTEINS
- Publication number 20150160215
- Publication date Jun 11, 2015
- Regeneron Pharmaceuticals, Inc.
- JAMES P. FANDL
- G01 - MEASURING TESTING

Person

Patents Grantslast 30 patents

Human antibodies to ebola virus glycoprotein

VEGF traps and mini-traps and methods for treating ocular disorders...

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...

Human antibodies to Ebola virus glycoprotein

Methods for treating allergy and enhancing allergen-specific immuno...

Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding f...

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...

Human antibodies to Ebola virus glycoprotein

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding f...

Methods for treating allergy and enhancing allergen-specific immuno...

Methods for treating allergy and enhancing allergen-specific immuno...

Isolating cells expressing secreted proteins

Human antibodies to Ebola virus glycoprotein

Human antibodies to Middle East Respiratory Syndrome—coronavirus sp...

Methods for treating allergy and enhancing allergen-specific immuno...

Isolating cells expressing secreted proteins

Human antibodies to Ebola virus glycoprotein

Human antibodies to NAv1.7

Human antibodies to ebola virus glycoprotein

Human antibodies to middle east respiratory syndrome—coronavirus sp...

Anti-PCSK9 antibodies with pH-dependent binding characteristics

Isolating cells expressing secreted proteins

Receptor based antagonists and methods of making and using

Methods of treating diseases with a VEGF antagonist

Isolating cells expressing secreted proteins

IL-1 receptor based cytokine traps and method of using

Use of an IL-1 antagonist for treating arthritis

Methods of treating anemia by inhibition of vascular endothelial gr...

Therapeutic method for treating bone formation diseases

Morphogenic protein

Patents Applicationslast 30 patents

HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN

COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND CO...

VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS...

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...

METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNO...

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding F...

IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS

COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND CO...

VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS...

HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN

Isolating Cells Expressing Secreted Proteins

Multivalent Antigen-Binding Proteins

METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNO...

HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN

Isolating Cells Expressing Secreted Proteins

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus...

HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN

Methods for Treating Allergy and Enhancing Allergen-Specific Immuno...

Methods for Treating Allergy and Enhancing Allergen-Specific Immuno...

HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus...

MULTIVALENT ANTIGEN-BINDING PROTEINS

MULTIVALENT ANTIGEN-BINDING PROTEINS

Isolating Cells Expressing Secreted Proteins

Human Antibodies to Ebola Virus Glycoprotein

ISOLATING CELLS EXPRESSING SECRETED PROTEINS

HUMAN ANTIBODIES TO NAV1.7

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus...

MUTIVALENT ANTIGEN-BINDING PROTEINS

ISOLATING CELLS EXPRESSING SECRETED PROTEINS